Common dietary supplements for cognitive health

Aging Health

Volumn 8, Issue 1, 2012, Pages 89-97

  Gestuvo, M K ^a   Hung, W W ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

3 fatty acids; antioxidants; cognitive impairment; dementia; dietary supplements; folate; ginkgo biloba; vitamin B12; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CITICOLINE; CYANOCOBALAMIN; FOLIC ACID; HERBACEOUS AGENT; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLACEBO; PYRIDOXINE; RETINOL; VITAMIN D;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BEHAVIOR DISORDER; COGNITION; DEMENTIA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; EMOTIONAL DISORDER; GINKGO BILOBA; GINSENG; HEALTH CARE COST; HUMAN; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; REVIEW; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

EID: 84856603724     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.11.92     Document Type: Review

References (77)

1. Bernstein AB, Remsburg RE. Estimated prevalence of people with cognitive impairment: results from nationally representative community and institutional surveys. Gerontologist 47(3), 350-354 (2007). (Pubitemid 47308974)
2. Ravaglia G, Forti P, Montesi F et al. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. J. Am. Geriatr. Soc. 56(1), 51-58 (2008).
3. Luck T, Luppa M, Briel S, Riedel-Heller SG. Incidence of mild cognitive impairment: a systematic review. Dement. Geriatr. Cogn. Disord. 29(2), 164-175 (2010).
4. Unverzagt FW, Gao S, Baiyewu O et al. Prevalence of cognitive impairment. Neurology 57(9), 1655-1662 (2001).
5. Plassman BL, Langa KM, Fisher GG et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology 29(1-2), 125-132 (2007). (Pubitemid 350191430)
6. Alzheimer's Association; Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 7(2), 208-244 (2011).
7. Craft S, Cholerton B, Reger M. Cognitive changes associated with normal and pathological aging. In: Hazzard's Geriatric Medicine and Gerontology (6th Edition). Halter JB, Ouslander JG, Tinetti ME, Studenski S, High KP, Asthana S (Eds). McGraw-Hill Medical, New York, NY, USA (2009).
8. Manolio T, Olson J, Longstreth W. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr. Hypertens. Rep. 5(3), 255-261 (2003). (Pubitemid 38914969)
9. Okonkwo OC, Cohen RA, Gunstad J, Tremont G, Alosco ML, Poppas A. Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. Cerebrovasc. Dis. 30(4), 362-373 (2010).
10. Yaffe K, Ackerson L, Tamura MK et al. Chronic kidney disease and cognitive function in older adults: findings from the Chronic Renal Insufficiency Cohort Cognitive Study. J. Am. Geriatr. Soc. 58(2), 338-345 (2010).
11. Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 180(2), 134-137 (2009).
12. Wang LY, Leverenz JB, Larson EB et al. Cognitive impairment in older adults without dementia: clinical and pathologic outcomes in a community-based sample. J. Geriatr. Psychiatry Neurol. 22(4), 256-265 (2009).
13. Ganguli M, Snitz BE, Saxton JA et al. Outcomes of mild cognitive impairment by definition: a population study. Arch. Neurol. 68(6), 761-767 (2011).
14. Steffens DC, Snowden M, Fan MY, Hendrie H, Katon WJ, Unutzer J. Cognitive impairment and depression outcomes in the IMPACT study. Am. J. Geriatr. Psychiatry 14(5), 401-409 (2006).
15. Feng L, Scherer SC, Tan BY, Chan G, Fong NP, Ng TP. Comorbid cognitive impairment and depression is a significant predictor of poor outcomes in hip fracture rehabilitation. Int. Psychogeriatr. 22(02), 246-253 (2010).
16. Artero S, Touchon J, Ritchie K. Disability and mild cognitive impairment: a longitudinal population-based study. Int. J. Geriatr. Psychiatry 16(11), 1092-1097 (2001). (Pubitemid 33089273)
17. Luppa M, Riedel-Heller S, Luck T et al. Age-related predictors of institutionalization: results of the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Soc. Psychiatry Psychiatr. Epidemiol. doi:10.1007/s00127-010-0333-9 (2010) (Epub ahead of print).
18. Laditka SB, Corwin SJ, Laditka JN et al. Attitudes about aging well among a diverse group of older Americans: implications for promoting cognitive health. Gerontologist 49(S1), S30-S39 (2009).
19. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat. Report (12), 1-23 (2008).
20. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300(24), 2867-2878 (2008).
21. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch. Intern. Med. 165(3), 281-286 (2005). (Pubitemid 40216279)
22. Straus SE. Complementary and alternative medicine. In: Harrison's Principles of Internal Medicine (17th Edition). Fauci AS, Braunwald E, Kasper DL et al. (Eds). McGraw-Hill Medical, New York, NY, USA (2008).
23. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat. Report (18), 1-14 (2009).
24. Dunn JE, Weintraub S, Stoddard AM, Banks S. Serum alpha-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment. Neurology 68(9), 670-676 (2007). (Pubitemid 46667814)
25. Kales HC, Blow FC, Welsh DE, Mellow AM. Herbal products and other supplements: use by elderly veterans with depression and dementia and their caregivers. J. Geriatr. Psychiatry Neurol. 17(1), 25-31 (2004). (Pubitemid 38294538)
26. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 287(3), 337-344 (2002). (Pubitemid 34251967)
27. Snitz BE, O'Meara ES, Carlson MC et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 302(24), 2663-2670 (2009).
28. Maclennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog. Neurobiol. 67(3), 235-257 (2002). (Pubitemid 34880132)
29. Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 70(19 Pt 2), 1809-1817 (2008). (Pubitemid 351653954)
30. Carlson JJ, Farquhar JW, Dinucci E et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J. Am. Diet. Assoc. 107(3), 422-432 (2007). (Pubitemid 46281825)
31. Solomon PR, Adams F, Silver A, Zimmer J, Deveaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288(7), 835-840 (2002).
32. Dekosky ST, Williamson JD, Fitzpatrick AL et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 300(19), 2253-2262 (2008).
33. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst. Rev. 1, CD003120 (2009).
34. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69(13), 1777-1798 (2009).
35. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am. J. Clin. Nutr. 82(3), 627-635 (2005).
36. Malouf R, Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst. Rev. 4, CD004393 (2003).
37. Malouf R, Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst. Rev. 3, CD004326 (2003).
38. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst. Rev. 4, CD004514 (2008).
39. Ford AH, Flicker L, Alfonso H et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology 75(17), 1540-1547 (2010).
40. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med. 354(26), 2764-2772 (2006). (Pubitemid 43974194)
41. Aisen PS, Schneider LS, Sano M et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300(15), 1774-1783 (2008).
42. Nahin RL, Pecha M, Welmerink DB, Sink K, Dekosky ST, Fitzpatrick AL. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J. Am. Geriatr. Soc. 57(7), 1197-1205 (2009).
43. Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst. Rev. 3, CD002854 (2008).
44. Vatassery GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am. J. Clin. Nutr. 70(5), 793-801 (1999). (Pubitemid 29512902)
45. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J. Am. Geriatr. Soc. 48(10), 1285-1291 (2000).
46. Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement. Geriatr. Cogn. Disord. 20(1), 45-51 (2005). (Pubitemid 40981178)
47. Kang JH, Cook N, Manson J, Buring JE, Grodstein F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch. Intern. Med. 166(22), 2462-2468 (2006). (Pubitemid 44913230)
48. Kang JH, Cook NR, Manson JE, Buring JE, Albert CM, Grodstein F. Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease. Circulation 119(21), 2772-2780 (2009).
49. Devore EE, Grodstein F, Van Rooij FJ et al. Dietary antioxidants and long-term risk of dementia. Arch. Neurol. 67(7), 819-825 (2010).
50. Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352(23), 2379-2388 (2005). (Pubitemid 40958434)
51. Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336(17), 1216-1222 (1997). (Pubitemid 27183651)
52. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142(1), 37-46 (2005).
53. Lonn E, Bosch J, Yusuf S et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293(11), 1338-1347 (2005). (Pubitemid 40381486)
54. Dionisi F, Calder P. Omega 3 fatty acids for the treatment of dementia and cognitive impairment (Protocol). Cochrane Database Syst. Rev. 2, CD009002 (2011).
55. Lim WS, Gammack JK, Van Niekerk J, Dangour AD. Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst. Rev. 1, CD005379 (2006).
56. Quinn JF, Raman R, Thomas RG et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease. JAMA 304(17), 1903-1911 (2010).
57. Van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr. 85(4), 1142-1147 (2007). (Pubitemid 46557933)
58. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch. Neurol. 62(12), 1849-1853 (2005). (Pubitemid 41785078)
59. Van De Rest O, Spiro A, Krall-Kaye E, Geleijnse JM, De Groot LCPGM, Tucker KL. Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study. J. Nutr. 139(12), 2329-2336 (2009).
60. Dangour AD, Allen E, Elbourne D et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 91(6), 1725-1732 (2010).
61. Quinn JF, Raman R, Thomas RG et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304(17), 1903-1911 (2010).
62. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J. Am. Coll. Cardiol. 54(7), 585-594 (2009).
63. De Caterina R. n-3 fatty acids in cardiovascular disease. N. Engl. J. Med. 364(25), 2439-2450 (2011).
64. Russell RM, Suter PM. Vitamin and trace mineral deficiency and excess. In: Harrison's Principles of Internal Medicine (18th Edition). Longo DL, Fauci AS, Kasper DL et al. (Eds). McGraw-Hill Medical, New York, NY, USA (2008).
65. Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch. Intern. Med. 167(20), 2184-2190 (2007). (Pubitemid 350106737)
66. Bjelakovic G, Gluud LL, Nikolova D et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 7, CD007470 (2011).
67. Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beauchet O. Dietary intake of vitamin D and cognition in older women. Neurology 75(20), 1810-1816 (2010).
68. Annweiler C, Allali G, Allain P et al. Vitamin D and cognitive performance in adults: a systematic review. Eur. J. Neurol. 16(10), 1083-1089 (2009).
69. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J. Gerontol. A Biol. Sci. Med. Sci. 66(1), 59-65 (2011).
70. Serby MJ, Yhap C, Landron EY. A study of herbal remedies for memory complaints. J. Neuropsychiatry Clin. Neurosci. 22(3), 345-347 (2010).
71. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement. Geriatr. Cogn. Disord. 29(5), 467-474 (2010).
72. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst. Rev. 2, CD000269 (2005).
73. Jorissen BL, Brouns F, Van Boxtel MP et al. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr. Neurosci. 4(2), 121-134 (2001). (Pubitemid 34071732)
74. Geng J, Dong J, Ni H et al. Ginseng for cognition. Cochrane Database Syst. Rev. 12, CD007769 (2010).
75. Lee MS, Yang EJ, Kim JI, Ernst E. Ginseng for cognitive function in Alzheimer's disease: a systematic review. J. Alzheimers Dis. 18(2), 339-344 (2009).
76. US Census Bureau (2008). Percent Distribution of the Projected Population by Selected Age Groups and Sex for the United States: 2010 to 2050. www.census.gov/population/www/projections/summarytables.html (Accessed 19 August 2011)
77. Office of Dietary Supplements National Institutes of Health (2011). Background Information: Dietary Supplements. http://ods.od.nih.gov/factsheets/ DietarySupplements (Accessed 12 December 2011)